Abstract
Clozaril Approved for Reducing Risk of Suicide
This article discusses the approval of Clozaril by the American Food & Drug Administration for the reduction of recurrent suicidal behavior. Information about schizophrenia, for which the drug was originally prescribed, is included. Side effects of Clozaril are listed. (SC)